KNRX

Knorex Ltd. (KNRX) Risks & Opportunities Analysis (2026)

Invetso Score: 3.1/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 2.8 (Weak)

Current ratio of 0.42 and zero interest coverage indicate acute liquidity stress, leaving KNRX more exposed than better-capitalized peers to refinancing or working-capital shocks.

Days sales outstanding of 130 and a negative cash-conversion cycle of -454 days suggest collections and payables timing are highly stretched, increasing execution risk versus peers.

Net debt to EBITDA is negative, implying EBITDA is not covering leverage in a conventional sense and limiting KNRX’s flexibility relative to peers with positive earnings power.

Days payables outstanding of 585 signals reliance on supplier financing, which can pressure vendor terms and disrupt operations more quickly than in peer models with stronger balance sheets.

Opportunities

Score:

If KNRX can normalize receivables collection, working-capital release could improve liquidity faster than peers with less extreme cash-cycle distortion.

Negative net debt to EBITDA suggests the balance-sheet metric is distorted by weak or negative EBITDA, so any earnings stabilization could improve peer-relative financial flexibility.

The absence of inventory ties up no cash in stock, which can support faster cash recovery than peers in inventory-heavy models if customer collections improve.

Overall Score

Score:

KNRX’s forward positioning is constrained by severe liquidity and working-capital stress that outweighs limited upside from potential cash-cycle normalization versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Knorex Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →